PneumRx Inc.
530 Logue Avenue
Mountain View
California
94043
United States
10 articles about PneumRx Inc.
-
BTG plc: Completion Of The Acquisition Of PneumRx Inc.
1/8/2015
-
Forbion Announces Sale Of Portfolio Company PneumRx Inc. To BTG plc For Up To EUR 385M (USD 475M)
12/4/2014
-
PneumRx Inc.'s RePneu Coil Becoming Therapy of Choice for Patients With Severe Emphysema
9/26/2013
-
First U.S. Patients Treated in PneumRx Inc. RENEW Pivotal Study for Treatment of Severe Emphysema
2/25/2013
-
PneumRx Inc. Buys Key Assets from Broncus Technologies, Inc. for Undisclosed Amount
5/21/2012
-
PneumRx Inc. Receives FDA Approval to Commence Pivotal Clinical Trial of RePneu Lung Volume Reduction Coil (RePneu LVRC) System
5/15/2012
-
PneumRx Inc. Raises $33 Million in Capital
1/5/2011
-
Forbion Capital Partners Leads $33 Million Series C financing of PneumRx Inc.
1/4/2011
-
PneumRx Inc. Announces CE Mark Approval for Its RePneu(R) Lung Volume Reduction Coil (LVRC(TM)) System
10/14/2010
-
PneumRx Inc. Raises $27 Million Round of Private Financing
3/6/2007